RBC Capital Reiterates Outperform on Johnson & Johnson, Maintains $175 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Shagun Singh has reiterated an Outperform rating on Johnson & Johnson (NYSE: JNJ) and maintained a price target of $175.
May 22, 2024 | 2:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital analyst Shagun Singh has reiterated an Outperform rating on Johnson & Johnson (NYSE: JNJ) and maintained a price target of $175.
The reiteration of an Outperform rating and a maintained price target of $175 by RBC Capital is a positive signal for investors, suggesting confidence in the company's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100